Literature DB >> 19390780

Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure.

A Georgi1, M Schneemann, K Tintelnot, R C Calligaris-Maibach, S Meyer, R Weber, P P Bosshard.   

Abstract

A 53-year old immunocompetent Swiss female is described who developed severe meningoencephalitis due to infection with Cryptococcus gattii 13 months following exposure on Vancouver Island, Canada. Diagnosis was based on cerebrospinal fluid (CSF) examination, i.e., positive India-ink staining, positive latex particle agglutination, and positive culture. Species identification was performed by growth on L-canavanine-glycine-bromthymol blue medium and by sequencing of the intergenic and internal transcribed spacer regions of the rRNA genes. After initial therapy with fluconazole by which the patient did not improve, therapy was changed to amphotericin B and flucytosine and later to high-dose fluconazole and amphotericin B. Despite long-term treatment and external drainage of the CSF, the patient's condition improved only slowly. The patient was discharged after 132 days of hospitalization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390780     DOI: 10.1007/s15010-008-8211-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  20 in total

1.  Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.

Authors:  Annemarie E Brouwer; Adul Rajanuwong; Wirongrong Chierakul; George E Griffin; Robert A Larsen; Nicholas J White; Thomas S Harrison
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

Review 2.  Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review.

Authors:  Karen F Macsween; Tihana Bicanic; Annemarie E Brouwer; Henry Marsh; Derek C Macallan; Thomas S Harrison
Journal:  J Infect       Date:  2005-11       Impact factor: 6.072

3.  Cryptococcus neoformans var gattii in Europe.

Authors:  K H Kohl; H Hof; A Schrettenbrunner; H P Seeliger; K J Kwon-Chung
Journal:  Lancet       Date:  1985-06-29       Impact factor: 79.321

4.  Diversity among strains of Cryptococcus neoformans var. gattii as revealed by a sequence analysis of multiple genes and a chemotype analysis of capsular polysaccharide.

Authors:  T Sugita; R Ikeda; T Shinoda
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

Review 5.  Do major species concepts support one, two or more species within Cryptococcus neoformans?

Authors:  Kyung J Kwon-Chung; Ashok Varma
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

Review 6.  Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

Authors:  D H Mitchell; T C Sorrell; A M Allworth; C H Heath; A R McGregor; K Papanaoum; M J Richards; T Gottlieb
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

7.  Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group.

Authors:  F Dromer; S Mathoulin; B Dupont; A Laporte
Journal:  Clin Infect Dis       Date:  1996-07       Impact factor: 9.079

8.  The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex.

Authors:  Masakazu Katsu; Sarah Kidd; Akikazu Ando; Maria Luiza Moretti-Branchini; Yuzuru Mikami; Kazuko Nishimura; Wieland Meyer
Journal:  FEMS Yeast Res       Date:  2004-01       Impact factor: 2.796

9.  Molecular typing of Cryptococcus neoformans by PCR fingerprinting, in comparison with serotyping and Fourier transform infrared-spectroscopy-based phenotyping.

Authors:  K Lemmer; D Naumann; B Raddatz; K Tintelnot
Journal:  Med Mycol       Date:  2004-04       Impact factor: 4.076

10.  Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing.

Authors:  M Bovers; F Hagen; E E Kuramae; T Boekhout
Journal:  Fungal Genet Biol       Date:  2007-12-23       Impact factor: 3.495

View more
  18 in total

1.  Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.

Authors:  K Datta; P Rhee; E Byrnes; G Garcia-Effron; D S Perlin; J F Staab; K A Marr
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

2.  Cryptococcus gattii infection in an immunocompetent patient from Southern Italy.

Authors:  Roberta Iatta; Ferry Hagen; Cecilia Fico; Nunzia Lopatriello; Teun Boekhout; Maria Teresa Montagna
Journal:  Mycopathologia       Date:  2011-11-05       Impact factor: 2.574

3.  A decade of experience: Cryptococcus gattii in British Columbia.

Authors:  Karen H Bartlett; Po-Yan Cheng; Colleen Duncan; Eleni Galanis; Linda Hoang; Sarah Kidd; Min-Kuang Lee; Sally Lester; Laura MacDougall; Sunny Mak; Muhammad Morshed; Marsha Taylor; James Kronstad
Journal:  Mycopathologia       Date:  2011-09-30       Impact factor: 2.574

Review 4.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 5.  Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Authors:  Edmond J Byrnes; Karen H Bartlett; John R Perfect; Joseph Heitman
Journal:  Microbes Infect       Date:  2011-06-01       Impact factor: 2.700

Review 6.  [Fungal infections of the central nervous system in the immunocompetent host].

Authors:  K Tintelnot; G S de Hoog; G Haase
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

7.  Environmental isolation of Cryptococcus gattii serotype B, VGI/MATα strains in southern Italy.

Authors:  Orazio Romeo; Fabio Scordino; Giuseppe Criseo
Journal:  Mycopathologia       Date:  2011-01-21       Impact factor: 2.574

8.  Successful Isavuconazole Salvage Therapy for a Cryptococcus deuterogattii (AFLP6/VGII) Disseminated Infection in a European Immunocompetent Patient.

Authors:  Maria Soledad Cuetara; Juan José Jusdado Ruiz-Capillas; Maria Pilar Nuñez-Valentin; Elena Rodríguez Garcia; Elena Garcia-Benayas; Ricardo Rojo-Amigo; Jose Carlos Rodriguez-Gallego; Ferry Hagen; María Francisca Colom
Journal:  Mycopathologia       Date:  2021-06-11       Impact factor: 2.574

Review 9.  Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.

Authors:  F P Gullo; S A Rossi; J de C O Sardi; V L I Teodoro; M J S Mendes-Giannini; A M Fusco-Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-04       Impact factor: 3.267

10.  Autochthonous and dormant Cryptococcus gattii infections in Europe.

Authors:  Ferry Hagen; M Francisca Colom; Daniëlle Swinne; Kathrin Tintelnot; Roberta Iatta; Maria Teresa Montagna; Josep M Torres-Rodriguez; Massimo Cogliati; Aristea Velegraki; Arjan Burggraaf; Alwin Kamermans; Johanna M Sweere; Jacques F Meis; Corné H W Klaassen; Teun Boekhout
Journal:  Emerg Infect Dis       Date:  2012-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.